U.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis.
Source: washingtontimes.com
Please follow and like us:
FDA panel weighs moving opioid antidote over the counter